London Genetics, Diaceutics Developing Software Tools for Biomarker Research | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – London Genetics and Diaceutics today announced a partnership to develop software tools to provide pharmaceutical companies with access to academic biomarker research groups.

The software will be based on the Diaceutics' Fusion platform, a series of proprietary web applications, and London Genetics' Biomarker Pathway platform.

Terms of the deal were not announced.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.